Overview
- Anderson’s mandate now runs through March 2029 after unanimous approval by Bayer’s supervisory board.
- He has advanced a multi-pronged approach to contain over 60,000 legacy glyphosate lawsuits inherited from the Monsanto takeover.
- Since 2023, Bayer has cut 11,000 positions, flattened hierarchies and pushed for greater employee autonomy to streamline operations.
- The company remains on track to achieve €2 billion in cost savings for 2026 thanks to job reductions and reorganized workflows.
- Despite persistent weakness in its agribusiness, Bayer’s share price has recovered by about €8 since April, trading above €27 per share.